GleamWall
中文EN

XENE Xenon Pharmaceuticals Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1582313 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-100.0%
TTM net income YoY-40.0%
TTM EPS YoY-20.6%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-50.3%
ROA-47.4%
ROIC (approx.)-48.4%
Asset turnover0.00x

Leverage & solvency

Liabilities / assets4.5%
Debt / equity0.00x
Current ratio21.19x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.83x
Accruals ratio-8.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$7.50M$0
R&D expense$300.94M$210.39M
SG&A expense$79.63M$68.90M
Operating income-$373.07M-$279.30M
Pretax income-$344.89M-$238.42M
Income tax$1.02M-$4.09M
Net income-$345.91M-$234.33M
EBITDA-$370.53M-$276.74M
EPS (basic)-4.36-3.01
EPS (diluted)-4.36-3.01
Weighted avg. shares (diluted)79.25M77.89M
Balance sheet
Cash & equivalents$199.16M$142.71M
Short-term investments$349.72M$484.19M
Receivables—$1.47M
Current assets$560.65M$635.26M
PP&E, net$8.72M$10.28M
Total assets$633.16M$798.14M
Current liabilities$41.79M$35.59M
Total liabilities$51.40M$43.24M
Shareholders' equity$581.76M$754.90M
Shares outstanding80.01M76.42M
Cash flow statement
Operating cash flow-$279.12M-$181.39M
Capital expenditure$799,000$3.08M
Free cash flow-$279.92M-$184.46M
Investing cash flow$218.00M$165.00M
Financing cash flow$117.11M$12.13M
Depreciation & amortization$2.54M$2.56M
Stock-based compensation$53.71M$50.72M

Free plan shows the latest 2 periods; Pro shows all 14 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.